Active Ingredient: ERYTHROMYCIN ETHYLSUCCINATE
Proprietary Name: ERYTHROMYCIN ETHYLSUCCINATE
Dosage Form; Route of Administration: GRANULE; ORAL
Strength: EQ 200MG BASE/5ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A211204
Product Number: 001
Approval Date: Nov 1, 2019
Applicant Holder Full Name: AMNEAL PHARMACEUTICALS OF NEW YORK LLC
Marketing Status:
Prescription
Patent and Exclusivity Information
Active Ingredient: ERYTHROMYCIN ETHYLSUCCINATE
Proprietary Name: ERYTHROMYCIN ETHYLSUCCINATE
Dosage Form; Route of Administration: GRANULE; ORAL
Strength: EQ 400MG BASE/5ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A211204
Product Number: 002
Approval Date: Nov 1, 2019
Applicant Holder Full Name: AMNEAL PHARMACEUTICALS OF NEW YORK LLC
Marketing Status:
Prescription
Patent and Exclusivity Information